Stock markets continued their upward trajectory on March 7, 2025, with indices gaining nearly one percent on the weekly expiry day. Positive economic cues and strong corporate updates bolstered investor confidence, leading to heightened focus on several key stocks. Investors are closely tracking companies such as IndiGo, Apollo Hospitals, Hyundai, TCS, NMDC, Laurus Labs, and others due to significant corporate announcements and financial movements.
Apollo Hospitals has strengthened its presence in the diagnostics sector with its subsidiary, Apollo Health and Lifestyle Limited (AHLL), acquiring a controlling stake in Lucknow-based Care Diagnostics. This all-cash transaction will expand Apollo’s service offerings in northern India, reinforcing its position in the growing healthcare diagnostics market. Meanwhile, IndiGo has taken a major step in its international expansion by launching non-stop long-haul flights to Manchester and Amsterdam. These flights, scheduled to begin in July, will be operated with leased Boeing 787-9 aircraft, marking a strategic shift towards global connectivity.
In the automobile sector, Hyundai Motor India has experienced a shift in its domestic market positioning. Previously the second-largest passenger vehicle manufacturer in India, Hyundai has now fallen to fourth place in retail sales, trailing Maruti Suzuki, Mahindra & Mahindra, and Tata Motors. This shift underscores the increasing competition within the Indian automobile industry. On the technology front, Tata Consultancy Services (TCS) has strengthened its global financial services foothold by extending its partnership with Northern Trust, a firm managing $17.4 trillion in assets. TCS will implement its BaNCS Global Securities Platform across 99 markets to enhance Northern Trust’s custody operations.
The insurance sector is also witnessing growth, with Bajaj Finserv’s subsidiaries posting robust performance. Bajaj Allianz General Insurance collected Rs 1,219 crore in premiums in February, raising its annual total to Rs 20,006 crore. Similarly, Bajaj Allianz Life Insurance secured Rs 1,080.33 crore in new business premiums, bringing its cumulative total to Rs 10,469.77 crore. Infrastructure firm Kalpataru Projects has secured contracts worth Rs 2,306 crore, encompassing international transmission and distribution projects along with domestic construction contracts.
Biocon Biologics is advancing its U.S. market presence through a collaboration with Civica Inc. to supply affordable insulin aspart, reinforcing its commitment to expanding in the American pharmaceutical sector. Meanwhile, Rail Vikas Nigam Ltd (RVNL) has secured a Rs 156.36 crore contract for electrification and infrastructure enhancements from South Western Railway. Bharat Electronics Ltd (BEL) has received fresh defence contracts worth Rs 577 crore, covering electronic warfare systems, submarine communication solutions, and radar upgrades. Additionally, Laurus Labs has announced an investment of Rs 833 crore in a joint venture with Slovenia’s KRKA Pharma, maintaining a 51:49 ownership split.
Further boosting India’s high-speed rail initiatives, RITES has secured a Rs 27.96 crore contract to survey the Hyderabad-Bengaluru and Hyderabad-Chennai high-speed rail corridors using advanced LiDAR technology. In the real estate sector, Brigade Enterprises has unveiled Brigade Altius in Chennai’s IT hub, featuring three 43-floor towers across 6.5 acres, making it one of the city’s tallest developments. With markets maintaining their resilience, investors are closely evaluating these developments for potential investment opportunities.
